A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living with Obesity or Overweight and Diabetes
This research study is testing a new medicine called KAI-9531. It's for adults who are either overweight or have obesity and also live with diabetes. The main goal is to find out if KAI-9531 is safe and effective at helping people lose weight and improve their blood sugar control (measured by something called HbA1c) over roughly a year and a half. Participants will be randomly given either the active study medicine or a 'dummy' medicine (placebo), and neither they nor their doctors will know which one they are receiving. This is a common way to properly test new treatments. The study also looks at other health measures like waist size and cholesterol levels.
At a glance
What is this study about?
This research study is exploring a new treatment called KAI-9531 for adults living with both obesity or being overweight and diabetes. The main purpose is to see how well this new medicine works compared to a 'dummy' treatment (placebo) over 76 weeks, which is about a year and a half. They're particularly interested in whether it helps people lose a significant amount of weight and whether it improves their blood sugar levels, which is vital for managing diabetes. Improving these areas could really help people's overall health and quality of life.
To make sure the study results are fair and accurate, some participants will receive the actual KAI-9531 medicine, while others will receive a placebo. No one involved – not the participants, the doctors, or the research team – will know who is getting which. This is called a 'double-blind' study and it's considered the best way to test new medicines without bias. Researchers will carefully monitor everyone's health throughout the study.
Beyond weight loss and blood sugar control, the study will also look at other important health markers. These include changes in waist circumference, blood pressure, cholesterol levels, and how people feel about their quality of life and eating habits. This comprehensive approach helps researchers understand the full impact of KAI-9531 on people's health.
Key takeaways
- This study is testing a new medicine (KAI-9531) for people with obesity or who are overweight and have diabetes.
- The main goals are to see if it helps with weight loss and improves blood sugar control.
- Participants will receive either the active medicine or a placebo, weekly, for about 1.5 years.
- Neither you nor your doctor will know which treatment you are receiving.
- The study involves regular clinic visits for health checks and monitoring.
Who may be eligible?
This study is looking for adults aged 18 and over, both men and women, who are currently living with obesity or are overweight and have been diagnosed with diabetes.
There will be specific health criteria that researchers will look at to make sure the study medicine is safe for you and that the results of the study are clear. For example, they might check for certain medical conditions, medications you are currently taking, or recent changes in your health.
If you're interested in taking part, the research team will explain all the requirements in detail and carry out some health checks to see if this study is right for you. It's important that you meet all the criteria to ensure your safety and the quality of the research.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of diabetes?
- Are you considered overweight or living with obesity?
- Are you able to attend regular clinic visits for about a year and a half?
What does participation involve?
If you join this study, you'll be involved for about a year and a half (76 weeks). You'll receive the study medicine, KAI-9531, or a placebo (inactive medicine), as an injection once a week. You won't know which one you're getting. You'll have regular visits to the clinic where the study team will carry out health checks, take blood samples, measure your weight and waist circumference, and ask you about your health and how you're feeling. They'll also check your blood pressure and other vital signs. After the main treatment period, there will likely be a follow-up period to see how you're doing. All visits, tests, and medicines related to the study will be provided at no cost.
Potential risks and benefits
Locations (6)
- —UnverifiedHungary
- —UnverifiedPoland
- —UnverifiedBulgaria
- —UnverifiedGermany
- —UnverifiedCzechia
- —UnverifiedSpain
Common questions
What is KAI-9531?
KAI-9531 is a new medicine being tested in this study to see if it can help people manage their weight and blood sugar levels.
What is a placebo?
A placebo is a 'dummy' medicine that looks exactly like the study medicine but contains no active drug. It helps researchers compare the real effects of the new medicine.
How long will the study last?
The study will last for about 76 weeks, which is roughly a year and a half.
Will I know if I'm getting the real medicine or the placebo?
No, neither you nor your doctor will know whether you are receiving KAI-9531 or the placebo during the study. This is common practice to ensure fair results.
What does 'HbA1c' mean?
HbA1c is a blood test that shows your average blood sugar level over the past two to three months, which is important for managing diabetes.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.